Long-Term Results of Stenting of Left Main Coronary Artery Lesions: Experience of One Hospital
Abstract
The aim. To study the effectiveness of left main coronary artery (LMCA) stenting in patients with coronary heart disease and to optimize the choice of percutaneous coronary intervention technique based on the experience of one clinic.
Materials and methods. The study, which was conducted at the National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine, included 107 patients with LMCA disease, who underwent stenting from January 2019 to December 2023. During the study, the patients were divided into two groups. One group underwent stenting using the single-stent method (44 patients, 41.1%), while the other group underwent stenting using the double-stent method (63 patients, 58.9%).
Results. In the group of surveyed patients after stenting, an analysis was conducted regarding adherence to drug therapy and achievement of target lipid spectrum levels. It was found that one of the reasons for the active progression of atherosclerosis can be considered low adherence to drug therapy. A group of patients with recurrence of angina after stenting, the cause of which was restenosis in the stented segment, was analyzed. In the analysis of the frequency of repeated interventions in patients with hemodynamically significant lesions of the LMCA, who initially underwent stenting, it was found that 24.5% of patients (n = 24) underwent stenting again at the second visit and only 4 patients (4.1%) underwent bypass surgery, which is statistically significant (p ≤ 0.001).
Conclusions. LMCA stenting is an effective way of treating patients with hemodynamically significant damage to it (effectiveness of the technique is 71.4%). Recurrence of angina was observed in 28 patients (28.6%). Both single-stent and double-stent procedures are effective: recurrence of angina was observed in 13.3% and 15.3% of cases, respectively. One of the main reasons for the recurrence of angina pectoris is the progression of atherosclerosis in new locations (39.3%) and restenosis in stenting segment (39.3%).
References
- Fajadet J, Chieffo A. Current management of left main coronary artery disease. Eur Heart J. 2012;33(1):36-50b. https://doi.org/10.1093/eurheartj/ehr426
- Stone GW, Kappetein AP, Sabik JF, Pocock SJ, Morice MC, Puskas J, et al.; EXCEL Trial Investigators. Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease. N Engl J Med. 2019;381(19):1820-1830. https://doi.org/10.1056/NEJMoa1909406
- Stone GW, Sabik JF, Serruys PW, Simonton CA, Généreux P, Puskas J, et al.; EXCEL Trial Investigators. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. N Engl J Med. 2016;375(23):2223-2235. https://doi.org/10.1056/NEJMoa1610227
- Mäkikallio T, Holm NR, Lindsay M, Spence MS, Erglis A, Menown IB, et al.; NOBLE study investigators. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet. 2016;388(10061):2743-2752. https://doi.org/10.1016/S0140-6736(16)32052-9
- Holm NR, Mäkikallio T, Lindsay MM, Spence MS, Erglis A, Menown IBA, et al.; NOBLE investigators. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial. Lancet. 2020;395(10219):191-199. https://doi.org/10.1016/S0140-6736(19)32972-1
- Palmerini T, Serruys P, Kappetein AP, Genereux P, Riva DD, Reggiani LB, et al. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients. Am Heart J. 2017;190:54-63. https://doi.org/10.1016/j.ahj.2017.05.005
- Punamiya K, Jha T, Punamiya V, Pradhan J. IVUS determination of normal left main stem artery size and plaque burden, and correlation with body surface area in an Indian population. AsiaIntervention. 2022;8(2):116-122. https://doi.org/10.4244/AIJ-D-22-00041
- Goel PK, Liladhar Vora P, Kumar Sahu A, Khanna R. Left main coronary artery diameter - A correlation between intravascular ultrasound and quantitative coronary angiography. Indian Heart J. 2021;73(5):660-663. https://doi.org/10.1016/j.ihj.2021.09.009
- Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541-2619. https://doi.org/10.1093/eurheartj/ehu278
- Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(3):e18-e114. https://doi.org/10.1161/CIR.0000000000001038
- Medina A, Suárez de Lezo J, Pan M. Una clasificación simple de las lesiones coronarias en bifurcación [A New Classification of Coronary Bifurcation Lesions]. Rev Esp Cardiol. 2006;59(2):183. Spanish. PubMed PMID: 16540043.
